The study, published in the journal Annals of Epidemiology, is based on the analysis of antibody tests conducted using 15,101 samples collected throughout New York state. A total of 1,887 samples showed evidence of reactive antibodies to the new coronavirus.
Based on that data, researchers estimated that cumulative incidence of coronavirus infection through March 29 was 14 percent in New York, corresponding to 2.1 million infected adults.
The cumulative incidence was higher among Hispanic/Latino residents (29.2 percent), Black residents (20.2 percent) and Asian residents (12.4 percent) than white residents (8.1 percent).
Antibody tests have limitations, including the risk of false positives and the fact that the tests cannot be used to determine immunity to the new virus, according to the CDC. Read more about its limitations here.
More articles on public health:
3 likely reasons Ohio hasn’t seen COVID-19 surge weeks after reopening
COVID-19 antibodies may only last 2 months, small study suggests
Where new COVID-19 cases are rising, falling and staying the same — June 18
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
